Company Overview and News

0
Emmerson Resources substantial shareholder increases interest through on-market purchases

2018-06-28 proactiveinvestors.com.au
Emmerson Resources Limited (ASX:ERM) substantial shareholder Noontide Investments Ltd has increased its holding to 14.8% from 13.5% through a series of on-market transactions.
ERM EMMRF

0
Emmerson Resources adds to gold mine portfolio at Tennant Creek Mineral Field

2018-06-24 proactiveinvestors.com.au
Emmerson Resources Ltd (ASX:ERM) managing director Rob Bills speaks to Proactive Investors about the latest news from the Tennant Creek Mineral Field, in Australia's Northern Territory. The explorer and producer holds a lot of land in the area, with a number or projects at various stages of development, from early-stage surveying work through to gold bar production.
ERM EMMRF

0
Emmerson Resources drills out mine potential at Mauretania

2018-06-20 proactiveinvestors.com.au
Emmerson Resources Ltd (ASX:ERM) has received results from initial drilling at Mauretania within the Tennant Creek Mineral Field (TCMF) in the Northern Territory.
ERM EMMRF

3
Emmerson Resources reveals early stage copper-gold discovery in New South Wales

2018-06-14 proactiveinvestors.com.au
Emmerson Resources Limited (ASX:ERM) has received encouraging results from the first pass fieldwork at the Whatling Hill copper-gold prospect within its Fifield project in New South Wales.
NCMGF NCM NCMGY EVN AMI RRL 3993 CAHPF ERM RGRNF EMMRF

0
Emmerson Resources makes 'a very exciting discovery' at Whatling Hill in NSW

2018-06-14 proactiveinvestors.com.au
Emmerson Resources Ltd (ASX:ERM) managing director Rob Bills tells Proactive Investors about the explorer and producer's discovery of what could be a large porphyry copper system at Whatling Hill; part of the Fifield Project, which in turn is part of the company's exploration portfolio in NSW, Australia.
ERM EMMRF

0
Emmerson Resources makes 'a very exciting discovery' at Wattling Hill in NSW

2018-06-13 proactiveinvestors.com.au
Emmerson Resources Ltd (ASX:ERM) managing director Rob Bills tells Proactive Investors about the explorer and producer's discovery of what could be a large porphyry copper system at Wattling Hill; part of the Fifield Project, which in turn is part of the company's exploration portfolio in NSW, Australia.
ERM EMMRF

0
'A fantastic step forward' for commercial production at Emmerson Resources

2018-06-12 proactiveinvestors.com.au
Emmerson Resources Ltd (ASX:ERM) managing director Rob Bills tells Proactive Investors all the details of the explorer and producer's recent agreement with Territory Resources Ltd (ASX:TTY).
ERM EMMRF

0
Alliance to develop Tennent Creek processing hub

2018-05-31 australianmining.com.au
Emmerson Resources has formed a strategic alliance with Territory Resources that will lead to the development of a processing hub to support small mines near Tennant Creek in the Northern Territory.
ERM EMMRF

0
Emmerson Resources signs deal to build processing facility for its small mines

2018-05-31 proactiveinvestors.com.au
Emmerson Resources Limited (ASX:ERM) has entered into a binding agreement to sell its mothballed Warrego Mill Lease in Western Australia to Territory Resources Ltd.
ERM EMMRF

2
Emmerson Resources gets overwhelming shareholder support for Tennant Creek strategy

2018-05-21 proactiveinvestors.com.au
Emmerson Resources Ltd’s (ASX:ERM) shareholders have overwhelmingly voted to formally approve the restructuring of the Tennant Creek Mineral Field joint venture with Evolution Mining (ASX:EVN).
EVN CAHPF ERM EMMRF

2
Evolution JV restructure gets green light

2018-05-21 australianmining.com.au
Evolution Mining and Emmerson Resources will move forward with the proposed restructure of their joint venture in the Northern Territory.
EVN CAHPF ERM EMMRF

2
Emmerson Resources shareholders overwhelming support joint venture restructure

2018-05-20 proactiveinvestors.com.au
Emmerson Resources Ltd (ASX:ERM) managing director Rob Bills updates Proactive Investors, as the company announces the vast majority of its shareholders have overwhelmingly voted to formally approve the restructuring of the Tennant Creek Mineral Field joint venture with Evolution Mining (ASX:EVN).
EVN CAHPF ERM EMMRF

2
Emmerson Resources completes airborne survey and commences drill program

2018-05-07 proactiveinvestors.com.au
Emmerson Resources Ltd (ASX:ERM) managing director Rob Bills updates Proactive Investors on activities across the company’s Tennant Creek Project in the Northern Territory.
EVN CAHPF ERM EMMRF

2
Emmerson Resources begins survey for further cobalt, copper and gold at Tennant Creek

2018-04-17 proactiveinvestors.com.au
Emmerson Resources Ltd (ASX:ERM) has commenced a 680-line kilometre airborne geophysical survey to pinpoint further high-grade cobalt, copper and gold deposits within the Tennant Creek Project in the Northern Territory.
EVN CAHPF ERM EMMRF

0
Emmerson Resources accelerating exploration programme following stellar results

2018-04-11 proactiveinvestors.com.au
Rob Bills, managing director of Emmerson Resources Ltd (ASX:ERM), reveals the positive implications of assay results demonstrating high-grades of cobalt, copper and gold at Jasper Hills within the company's Tennant Creek Project in the Northern Territory.
ERM EMMRF

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to ASX:ERM / EMMERSON RESOURCES LIMITED on message board site Silicon Investor.

GENI: GenesisIntermedia.com Inc Longer term short term day trades.
NWL: Newell Rubbermaid, Inc. Robert Zimmerman, Bob Dylan, Dylan
Qi cybermoney Longer-Term Market Trends
Bush-The Mastermind behind 9/11? Synopsys (SNPS) Steady long term growth
Thermo Electron (TMO) Buckeyu0027s Bottom Bounce Short Term Picks (CDN ONLY)